CRISPR-based diagnostic methods are poised to have a significant impact on global health, and now, with the first FDA-emergency authorized use of CRISPR technology, this impact is being brought directly to the fight against the global COVID-19 pandemic.

Join us to learn more about how Sherlock Biosciences has been driving CRISPR innovation and how that mission, with IDT's support, has led to the Sherlock™ CRISPR SARS-CoV-2 kit. Our speakers will provide an overview of SHERLOCK CRISPR technology and how it has been adapted for specific and sensitive detection of SARS-CoV-2 to increase testing capacity.

Objectives:

• Describe the basics of how the SHERLOCK CRISPR-based diagnostic tool works
• Overview of the Sherlock™ CRISPR SARS-CoV-2 kit and performance
• Understand the benefits of the Sherlock CRISPR SARS-CoV-2 kit and how it can help your lab increase testing capacity

A live Q&A session will follow the presentations, offering you a chance to pose questions.